As disclosed on November 4, 2024, Sonder filed its quarterly reports on Form 10-Q for the fiscal ... information and is now in full compliance with all Nasdaq requirements.

On November 6, a recent SEC filing unveiled that Thomas St. Dennis, Director at FormFactor (NASDAQ:FORM) made an insider ... Check Out The Full List Of FormFactor's Insider Trades.

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) (a) Full name of ...

Q3 2024 Earnings Call Transcript November 15, 2024 Operator: Good morning, everyone. Thank you for standing by, and welcome ...

Q3 2024 Earnings Call Transcript November 15, 2024 Operator: Greetings, and welcome to the Drilling Tools International Third ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Conference call. As a reminder, today’s call is being recorded, and your participation implies consent to such recording. At this time, all ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to Forian Inc. Third Quarter 2024 ...

The financial services company also raised its full-year outlook ... Revenue for the quarter increased to $697.12 million form $537.21 million in the previous year. The consensus estimate was ...

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) (a) Full name of ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good day, and thank you for standing by. Welcome to the Q3 2024 Invivyd Earnings Conference Call. At this time, all participants are in a ...

Celularity Raises Full Year 2024 Expected Net Sales Guidance to $54 Million to $60 Million, Compared to Previous Guidance of $50 Million to $56 ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good day, everyone, and welcome to the Vivos Therapeutics Third ...